110 related articles for article (PubMed ID: 21539721)
1. Epac1 promotes melanoma metastasis via modification of heparan sulfate.
Baljinnyam E; Umemura M; De Lorenzo MS; Iwatsubo M; Chen S; Goydos JS; Iwatsubo K
Pigment Cell Melanoma Res; 2011 Aug; 24(4):680-7. PubMed ID: 21539721
[TBL] [Abstract][Full Text] [Related]
2. Exchange protein directly activated by cyclic AMP increases melanoma cell migration by a Ca2+-dependent mechanism.
Baljinnyam E; De Lorenzo MS; Xie LH; Iwatsubo M; Chen S; Goydos JS; Nowycky MC; Iwatsubo K
Cancer Res; 2010 Jul; 70(13):5607-17. PubMed ID: 20551063
[TBL] [Abstract][Full Text] [Related]
3. Epac increases melanoma cell migration by a heparan sulfate-related mechanism.
Baljinnyam E; Iwatsubo K; Kurotani R; Wang X; Ulucan C; Iwatsubo M; Lagunoff D; Ishikawa Y
Am J Physiol Cell Physiol; 2009 Oct; 297(4):C802-13. PubMed ID: 19657062
[TBL] [Abstract][Full Text] [Related]
4. Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling.
Baljinnyam E; Umemura M; Chuang C; De Lorenzo MS; Iwatsubo M; Chen S; Goydos JS; Ishikawa Y; Whitelock JM; Iwatsubo K
Pigment Cell Melanoma Res; 2014 Jul; 27(4):611-20. PubMed ID: 24725364
[TBL] [Abstract][Full Text] [Related]
5. Antibody-based assay for N-deacetylase activity of heparan sulfate/heparin N-deacetylase/N-sulfotransferase (NDST): novel characteristics of NDST-1 and -2.
van den Born J; Pikas DS; Pisa BJ; Eriksson I; Kjellen L; Berden JH
Glycobiology; 2003 Jan; 13(1):1-10. PubMed ID: 12634318
[TBL] [Abstract][Full Text] [Related]
6. Distinct effects on heparan sulfate structure by different active site mutations in NDST-1.
Bengtsson J; Eriksson I; Kjellén L
Biochemistry; 2003 Feb; 42(7):2110-5. PubMed ID: 12590599
[TBL] [Abstract][Full Text] [Related]
7. Disturbed Ca2+ kinetics in N-deacetylase/N-sulfotransferase-1 defective myotubes.
Jenniskens GJ; Ringvall M; Koopman WJ; Ledin J; Kjellén L; Willems PH; Forsberg E; Veerkamp JH; van Kuppevelt TH
J Cell Sci; 2003 Jun; 116(Pt 11):2187-93. PubMed ID: 12692154
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the N-deacetylase domain from the heparan sulfate N-deacetylase/N-sulfotransferase 2.
Duncan MB; Liu M; Fox C; Liu J
Biochem Biophys Res Commun; 2006 Jan; 339(4):1232-7. PubMed ID: 16343444
[TBL] [Abstract][Full Text] [Related]
9. Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate.
Carter NM; Ali S; Kirby JA
J Cell Sci; 2003 Sep; 116(Pt 17):3591-600. PubMed ID: 12876215
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma.
Ricoveri W; Cappelletti R
Cancer Res; 1986 Aug; 46(8):3855-61. PubMed ID: 3731061
[TBL] [Abstract][Full Text] [Related]
11. Expression of the mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate.
Cheung WF; Eriksson I; Kusche-Gullberg M; Lindhal U; Kjellén L
Biochemistry; 1996 Apr; 35(16):5250-6. PubMed ID: 8611511
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of different isoforms of glucosaminyl N-deacetylase/N-sulfotransferase results in distinct heparan sulfate N-sulfation patterns.
Pikas DS; Eriksson I; Kjellén L
Biochemistry; 2000 Apr; 39(15):4552-8. PubMed ID: 10758005
[TBL] [Abstract][Full Text] [Related]
13. Role of Deacetylase Activity of N-Deacetylase/N-Sulfotransferase 1 in Forming N-Sulfated Domain in Heparan Sulfate.
Dou W; Xu Y; Pagadala V; Pedersen LC; Liu J
J Biol Chem; 2015 Aug; 290(33):20427-37. PubMed ID: 26109066
[TBL] [Abstract][Full Text] [Related]
14. Target selection of heparan sulfate hexuronic acid 2-O-sulfotransferase.
Smeds E; Feta A; Kusche-Gullberg M
Glycobiology; 2010 Oct; 20(10):1274-82. PubMed ID: 20554947
[TBL] [Abstract][Full Text] [Related]
15. Heparanases and tumor metastasis.
Nakajima M; Irimura T; Nicolson GL
J Cell Biochem; 1988 Feb; 36(2):157-67. PubMed ID: 3281960
[TBL] [Abstract][Full Text] [Related]
16. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis.
Gao L; Feng Y; Bowers R; Becker-Hapak M; Gardner J; Council L; Linette G; Zhao H; Cornelius LA
Cancer Res; 2006 Aug; 66(16):7880-8. PubMed ID: 16912161
[TBL] [Abstract][Full Text] [Related]
17. PKA and Epac1 regulate endothelial integrity and migration through parallel and independent pathways.
Lorenowicz MJ; Fernandez-Borja M; Kooistra MR; Bos JL; Hordijk PL
Eur J Cell Biol; 2008 Oct; 87(10):779-92. PubMed ID: 18635287
[TBL] [Abstract][Full Text] [Related]
18. ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma.
Ungerer C; Doberstein K; Bürger C; Hardt K; Boehncke WH; Böhm B; Pfeilschifter J; Dummer R; Mihic-Probst D; Gutwein P
Biochem Biophys Res Commun; 2010 Oct; 401(3):363-9. PubMed ID: 20851104
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of perlecan proteoglycan in metastatic melanomas.
Cohen IR; Murdoch AD; Naso MF; Marchetti D; Berd D; Iozzo RV
Cancer Res; 1994 Nov; 54(22):5771-4. PubMed ID: 7954396
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.
Lissitzky JC; Parriaux D; Ristorcelli E; Vérine A; Lombardo D; Verrando P
Cancer Res; 2009 Feb; 69(3):802-9. PubMed ID: 19176384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
